logo
ProjectForthcoming

EGFR protein condensation as a regulator of Ras activity

One of 10,000+ projects Taiyo tracks in Germany.

Source: EU Funding & Tenders Portal

The epidermal growth factor receptor (EGFR) is a key regulator of cell growth, division, and survival. Abnormal EGFR activity is implicated in many cancers, and while EGFR-targeted therapies have improved patient outcomes, acquired resistance also develops. Recent discoveries suggest that EGFR can form dynamic protein assembles “condensates” on the cell membrane—clusters of proteins comprising EGF

Status
Prospective
Sector
Education
Location
Germany
Updated
19 Nov 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about EGFR protein condensation as a regulator of Ras activity

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “EGFR protein condensation as a regulator of Ras activity” is an infrastructure initiative in the Education sector, located in Germany. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

forthcoming

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

The epidermal growth factor receptor (EGFR) is a key regulator of cell growth, division, and survival. Abnormal EGFR activity is implicated in many cancers, and while EGFR-targeted therapies have improved patient outcomes, acquired resistance also develops. Recent discoveries suggest that EGFR can form dynamic protein assembles “condensates” on the cell membrane—clusters of proteins comprising EGFR itself and effector molecules for downstream signaling that may profoundly affect how signals are transmitted to downstream pathways such as MAPK (Ras), a central driver of cancer cell proliferation. However, the role of these condensates in modulating signal transmission remains unknown. This project will use a model system—giant plasma membrane vesicles (GPMVs)—which preserve the complexity of cell membranes but eliminate cellular feedback loops, enabling precise control over the signaling environment. Working with world-leading experts at UC Berkeley (Prof. Jay T. Groves) and Goethe University Frankfurt (Prof. Mike Heilemann), I will: (1) determine the EGFR condensate formation and how cancer-associated EGFR mutations affect condensate formation; (2) reveal the relationship between condensation and Ras activation, including potential Ras assembly into nanoclusters; and (3) examine how EGFR interacts and co-condenses with other receptors such as MET, a known contributor to drug resistance. The study combines fluorescence imaging, quantitative single-molecule techniques, and biochemical reconstitution. Results will provide the first quantitative map linking EGFR condensation to Ras activation, offering fresh insights into resistance mechanisms and identifying potential new intervention points. The fellowship will also equip me with unique interdisciplinary expertise in reconstitution biophysics, single-molecule microscopy, and cancer signaling—skills that will position me to lead innovative, cross-disciplinary research at the interface of biophysics and oncology.

Location

Country

Germany

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Education

Article published date

2026-11-15

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project